Find uplifting stories about heroes, innovations, and solutions
34 results for "johns hopkins"
Johns Hopkins scientists discovered that hydrogen sulfide, the gas that smells like rotten eggs, plays a crucial role in protecting memory and brain health. Mice lacking the protein that produces this gas developed Alzheimer's-like symptoms, opening a promising new path for treatment.
Scientists at Johns Hopkins developed a nose-delivered vaccine that helps the body fight tuberculosis, the world's deadliest infectious disease. Early tests show it could shorten treatment times and prevent drug-resistant strains.
When Tim Evans was diagnosed with ALS on Valentine's Day 2014, he faced a choice: wait at home or use his remaining years to help others. He became the first volunteer in a Johns Hopkins study designed to improve quality of life for ALS patients.
A man with ALS chose purpose over despair, becoming the first volunteer in a Johns Hopkins study aimed at improving quality of life for patients. His decision turned a terminal diagnosis into a legacy of hope.
A man diagnosed with ALS on Valentine's Day 2014 chose to become the first volunteer in a Johns Hopkins study aimed at improving quality of life for others with the disease. Instead of waiting at home, Tim Evans is dedicating his remaining time to advancing research that could help thousands.
Doctors created virtual replicas of patients' hearts to test treatments before surgery, turning a risky three-hour procedure into a 30-minute success story. All ten patients with life-threatening irregular heartbeats are now healthy, compared to just 60% with traditional methods.
Tim Evans, diagnosed with ALS in 2014, chose to become the first volunteer in groundbreaking research at Johns Hopkins Medicine instead of letting his disease define his final chapter. His decision could help improve quality of life for thousands of ALS patients diagnosed each year.
Ten heart patients are now arrhythmia-free after doctors tested life-saving procedures on digital replicas of their hearts first. This breakthrough technology turned a procedure with a 60% success rate into one with perfect outcomes.
Johns Hopkins University just launched "job family reunions" to help over 200 employees discover new career paths without leaving the institution. The first event connected staff across administrative, research, and human resources roles with mentors and career development resources.
New research from Johns Hopkins reveals that infants aren't as oblivious as they seem. Their minds are actively processing complex information about safety and risk from a surprisingly young age.
A hormone already used to treat osteoporosis might reverse chronic back pain by stopping nerves from growing into damaged spine areas. Johns Hopkins researchers discovered the treatment repairs deteriorating spinal tissue at its source.
Scientists discovered that a common osteoporosis drug might eliminate chronic back pain by blocking pain nerves from growing into damaged spine tissue. The breakthrough could transform treatment for millions who suffer daily.
Clinically designed video games are showing real results for young people struggling with ADHD and depression, offering families a new path when traditional therapy wait times stretch for months. Johns Hopkins researchers found these specially designed games delivered modest but meaningful improvements that both kids and parents could see.
Matthew Hartshorn didn't just compete at the NCAA Championships—he shattered his own school record and claimed his third All-America honor. The senior's performance marked a historic moment for Johns Hopkins swimming.
A Johns Hopkins study found that a single dose of psilocybin helped smokers quit at six times the rate of nicotine patches. Even the researchers were stunned by how powerful the results turned out to be.
A Johns Hopkins study found that a single dose of psilocybin helped smokers quit at six times the rate of nicotine patches. It's the first potential new smoking cessation medication in 20 years.
A team of scientists across five countries just received $24 million to pursue something 300 million people are waiting for: a cure for hepatitis B. The five-year project brings together researchers from Brazil, India, Senegal, Uganda, and the United States to turn laboratory discoveries into real treatments.
A team of researchers across five countries just received $24 million to find a cure for hepatitis B, a virus that affects 300 million people worldwide. The five-year effort could finally bring hope to millions living with a disease that currently has no cure.
Johns Hopkins researchers created an AI blood test that detects liver disease years before symptoms appear, potentially helping 100 million Americans at risk. The test reads DNA fragment patterns instead of hunting for specific mutations.
A Johns Hopkins senior just became only the third fencer in school history to reach 300 career wins, leading her team to second place at nationals. The Blue Jays also captured their first sabre team championship in five years.
Showing 20 of 34